Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F1W80
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,956
Award facts
- Contract value 100% obligated
- $57,956.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on January 22, 2026, for 90-count tablets of Myrbetriq ER 50 mg. This firm fixed-price, non-set-aside contract has a ceiling value of $57,956.01 and is scheduled for completion by January 23, 2026. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle through December 2026 that enables the company to supply a wide range of pharmaceuticals and medical supplies to military healthcare programs worldwide.
The parent company Cencora, Inc., which operates under the AmerisourceBergen brand, holds the primary IDC with the Defense Logistics Agency and serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military treatment facilities. Myrbetriq is a prescription medication used for overactive bladder treatment, representing the type of specialized pharmaceutical product included within DLA's broad medical supply chain portfolio. This delivery order exemplifies the routine, competitively-awarded pharmaceutical procurement that occurs under the master contract vehicle to ensure military and veteran healthcare systems maintain adequate medication inventories.
Quick answers
Who was awarded contract SPE2DR26F1W80?
SPE2DR26F1W80 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1W80 worth?
The government has obligated $57,956 on SPE2DR26F1W80.
Is contract SPE2DR26F1W80 an order under another contract?
Yes. SPE2DR26F1W80 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W80 competed?
The extent of competition for SPE2DR26F1W80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award